Quality of life effects of androgen deprivation therapy in a prostate cancer cohort in New Zealand: can we minimize effects using a stratification based on the aldo-keto reductase family 1, member C3 rs12529 gene polymorphism?

BACKGROUND: Androgen deprivation therapy (ADT) is an effective palliation treatment in men with advanced prostate cancer (PC). However, ADT has well documented side effects that could alter the patient’s health-related quality of life (HRQoL). The current study aims to test whether a genetic stratif...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMC Urol
Main Authors: Karunasinghe, Nishi, Zhu, Yifei, Han, Dug Yeo, Lange, Katja, Zhu, Shuotun, Wang, Alice, Ellett, Stephanie, Masters, Jonathan, Goudie, Megan, Keogh, Justin, Benjamin, Benji, Holmes, Michael, Ferguson, Lynnette R.
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2016
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4971639/
https://ncbi.nlm.nih.gov/pubmed/27485119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-016-0164-4
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares